Fengbei Biotechnology: 35.9 million shares of new stocks will be listed on the main board on November 5th, warning of multiple risks.

Fengbei Bios announcement that the company's RMB ordinary shares will be listed on the main board of the Shanghai Stock Exchange on November 5, 2025, with the stock code 603334. The total share capital after the initial public offering is 143.5 million shares, with 35.9 million shares issued, all of which are new shares. The company reminds investors to pay attention to the risks of investing in the early stages of listing, including the loosening of price limits, limited circulating shares, valuation, and risks related to financing and securities lending. The issue price this time is 24.49 yuan per share, corresponding to a diluted price-to-earnings ratio of 30.47 times after deducting non-recurring items in 2024, which is lower than the industry average and the average level of comparable companies.